Abstract:CHCHD10 is a mitochondrial protein, in which multiple mutations were recently linked to familial ALS as well as sporadic ALS-FTLD(1-4). The ALS-linked CHCHD10 S59L mutation has been shown to reduce mitochondrial length and disorganize mitochondrial cristae morphology(1). Otherwise, the cellular function of CHCHD10 is completely unknown. While TDP-43 mutations are found in a small proportion of ALS and FTLD-TDP, TDP-43 pathology is also found in 59% of AD cases and also a large fraction of sporadic ALS and FTLD cases(5,6). Increasing evidence indicates that TDP-43 is highly neurotoxic, in large part, by inducing mitochondrial dysfunction(7,8). We utilized combinations of CHCHD10 knockdown and overexpression of wild type or mutant CHCHD10 (R15L & S59L) with/without TDP-43 in hippocampus-derived HT22 cells and primary neurons to assess mitochondrial health, apoptosis, as well as localization and interaction of CHCHD10 and TDP-43. In addition, we utilized a C. elegans model of har-1 (CHCHD10 ortholog) mutation or knockout for worm movement and mitochondrial health. In HT22 cells, wildtype and ALS/FTLD-linked R15L and S59L mutant Flag-CHCHD10 largely colocalized with mito-dsRed. However, significantly more R15L and S59L mutants were not colocalized with mitochondria compared to wild type CHCHD10. At the same time, R15L and S59L transfected cells showed more rounded and aggregated mitochondria, thereby reducing mitochondrial length. As such, recombinant His-tagged S59L variant showed reduced binding to isolated mitochondria, whereas recombinant R15L variant was consistently insoluble in E. Coli. While TDP-43 or CHCHD10 variants showed minimal toxicity per se, co-expression of TDP-43 with CHCHD10 mutations but not wildtype dramatically enhanced neurotoxicity, as evidenced by Annexin V/PI staining. Intriguingly, CHCHD10 mutations preferentially interacted with TDP-43 compared to wildtype. Both CHCHD10 knockdown and CHCHD10 mutations significantly reduced mitochondrial membrane potential and increased mitochondrial superoxide levels. In primary neurons, CHCHD10 mutations but not wildtype decreased the ratio of nuclear to cytoplasmic TDP-43 and reduced postsynaptic drebrin levels. In C. elegans, both the G73E mutation and knockout of har-1 significantly impaired worm movement and increased mitochondrial superoxide levels. We conclude that ALS/FTLD-linked CHCHD10 mutations and loss of CHCHD10 impair mitochondrial function principally via a pathway involving TDP-43 nuclear to mitochondrial localization.

Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Mitochondrial bioenergetics stimulates autophagy for pathological MAPT/Tau clearance in tauopathy neurons

Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice

Dysregulated expanded endocannabinoid system as therapeutic targets of amyotrophic lateral sclerosis

Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis

Tau phosphorylation suppresses oxidative stress-induced mitophagy via FKBP8 receptor modulation

Hyperphosphorylated Human Tau Accumulates at the Synapse, Localizing on Synaptic Mitochondrial Outer Membranes and Disrupting Respiration in a Mouse Model of Tauopathy

Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis

Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects

Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights

Small molecule modulation of a redox-sensitive stress granule protein dissolves stress granules with beneficial outcomes for familial amyotrophic lateral sclerosis models

CHCHD10 MUTATIONS SYNERGIZE WITH TDP-43 TO PROMOTE NEURONAL APOPTOSIS

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

Enhancing Mitochondrial Proteostasis Reduces Amyloid-Β Proteotoxicity.

P4‐090: Chchd10 Mutations Synergize with TDP‐43 to Promote Neuronal Apoptosis

Autophagy and ALS: mechanistic insights and therapeutic implications

An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress